Tigecycline Lock Therapy for Catheter-Related Bloodstream Infection Caused by KPC-Producing Klebsiella pneumoniae in Two Pediatric Hematological Patients

Antimicrob Agents Chemother. 2015 Dec;59(12):7919-20. doi: 10.1128/AAC.01855-15. Epub 2015 Oct 12.

Abstract

Catheter-related bacteremias carry high mortality rates in hematological patients. When a multidrug-resistant microorganism is involved, the catheter should ideally be removed; however, this approach is not always possible. Tigecycline lock therapy was used in two pediatric oncohematological patients with intravascular catheter-related infection due to KPC-producing Klebsiella pneumoniae. The catheter was salvaged in both cases, and the patients were later discharged. Our experience suggests the usefulness of this approach in treating this type of infection.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anemia, Aplastic / complications
  • Anemia, Aplastic / drug therapy
  • Anemia, Aplastic / immunology
  • Anemia, Aplastic / pathology
  • Anti-Bacterial Agents / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • Bacteremia / complications
  • Bacteremia / drug therapy*
  • Bacteremia / immunology
  • Bacteremia / pathology
  • Catheter-Related Infections / complications
  • Catheter-Related Infections / drug therapy*
  • Catheter-Related Infections / immunology
  • Catheter-Related Infections / pathology
  • Central Venous Catheters
  • Drug Administration Schedule
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Klebsiella Infections / complications
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / immunology
  • Klebsiella Infections / pathology
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / growth & development
  • Klebsiella pneumoniae / pathogenicity
  • Minocycline / analogs & derivatives*
  • Minocycline / therapeutic use
  • Tigecycline
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Tigecycline
  • Minocycline